Jennifer Lew, Chief Financial Officer at ADURO BIOTECH, INC. (ADRO), sold 37,202 shares at $4.08 ($152K) on 2019-04-08, disclosed to the SEC on 2019-04-10.
Open-market sale of $152k ADRO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.07 | 2,232 | $9K | 6.0% |
| 2 | $4.07 | 12,144 | $49K | 32.6% |
| 3 | $4.07 | 2,232 | $9K | 6.0% |
| 4 | $4.07 | 12,144 | $49K | 32.6% |
| 5 | $4.08 | 4,225 | $17K | 11.4% |
| 6 | $4.08 | 4,225 |
| $17K |
| 11.4% |
| Total | $4.07 avg | 37,202 | $152K | 100% |
| Filing → |
| ANNX | SELL | 2025-07-16 | $3K | — | Filing → |
| ANNX | SELL | 2025-02-20 | $20K | — | Filing → |
| ANNX | SELL | 2025-02-18 | $5K | — | Filing → |